Lithium Hydroxide → HCID 59497611, compound
Reaction equation
C[O:2][C:3](=[O:28])[CH2:4][CH2:5][N:6]1[C:10]2[CH:11]=[CH:12][CH:13]=[CH:14][C:9]=2[N:8]([CH2:15][C:16]2[CH:24]=[C:23]([Cl:25])[CH:22]=[C:21]3[C:17]=2[CH2:18][C:19](=[O:26])[NH:20]3)[C:7]1=[O:27].[OH-].[Li+]>O.O1CCOCC1>[Cl:25][C:23]1[CH:22]=[C:21]2[C:17]([CH2:18][C:19](=[O:26])[NH:20]2)=[C:16]([CH2:15][N:8]2[C:9]3[CH:14]=[CH:13][CH:12]=[CH:11][C:10]=3[N:6]([CH2:5][CH2:4][C:3]([OH:28])=[O:2])[C:7]2=[O:27])[CH:24]=1Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
3-[3-(6-Chloro-2-oxo-2,3-dihydro-1H-indol-4-ylmethyl)-2-oxo-2,3-dihydro-benzoimidazol-1-yl]-propionic acid methyl ester (34 mg 0.09 mmol) is dissolved in dioxane water (2 mL/2 mL) and lithium hydroxide (18 mg, 0.45 mmol) is added in one portion. The reaction is stirred for one hour then the solvents evaporated in vacuo. The crude material is purified by preparative reverse phase LC to give the title compound (12 mg 0.03 mmol, 36%). LCMS (ESMS): m/z 387.1 (M+H+).
Workup
- customthe solvents evaporated in vacuo
- customThe crude material is purified by preparative reverse phase LC
Sources & evidence
- ORD record
- ord-f9ed6f589a7f408b99d44975ba774f83
- Source dataset
- uspto-grants-2015_10
- Patent number
- US09150556B2
Reaction notes
Loading…